Active Crohn's disease patients show a distinctive expansion of circulating memory CD4+CD45RO+CD28null T cells

Journal of Clinical Immunology

Volumn 24, Issue 2, 2004, Pages 185-196

  García De Tena, Jaime ^a,b   Manzano, Luis ^a,c   Leal, Juan Carlos ^b   San Antonio, Esther ^a   Sualdea, Verónica ^a   Álvarez Mon, Melchor ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

CD28; CD4 T cells; CD45RO; Crohn's disease; Inflammatory bowel disease

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CROHN DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MEMORY CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; ULCERATIVE COLITIS;

ADULT; ANTIGENS, CD28; ANTIGENS, CD45; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; MALE;

EID: 1842503193     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOCI.0000019784.20191.7f     Document Type: Conference Paper

References (52)

1. Fiocchi C: Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 115:182-205, 1998
2. Elson CO: The immunology of inflammatory bowel disease. In Inflammatory Bowel Disease, JB Kirsner(ed). New York. Raven Press, 2000, pp 208-239
3. Podolsky DK: Inflammatory bowel disease. N Engl J Med 347:417-429, 2002
4. Sanahan F: Crohn's disease. Lancet 359:62-69, 2002
5. Dulton RW, Bradley LM, Swain L: T cell memory. Annu Rev Immunol 16:201-223, 1998
6. Sprent J, Surh CD: Generation and maintenance of memory T cells. Curr Opin Immunol 13:248-254, 2001
7. Sprent J. Surh CD: T cell memory. Annu Rev Immunol 20:551-579, 2002
8. + phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 110:1008-1019, 1996
9. Meenan J, Spaans J, Grools TA, Pals ST, Tytgat GN, van Deventer SJ: Altered expression of α4β7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut 40:241-246, 1997
10. Mariani P, Bacheloni A, D'Alessandro M, Lomanto D, Mazzocchi P, Speranza V: Effector Th-1 cells with cyloloxic function in the intestinal lamina propria of patients with Crohn's disease. Dig Dis Sci 45:2029-2035, 2000
11. Chakir J, Laviolelle M, Turcotte H, Boulet M, Boutet LP: Cytokine expression in the lower airways of nonasthmatics subjects with allergic rhinitis: Influence of natural allergen exposure. J Allergy Clin Immunol 106:904-910, 2000
12. Wu XM, Osoegawa M, Yamasaki K, Kawano Y, Ochi H, Horiuchi I, Minohara M, Ohyagi Y, Yamada T, Kira JI: Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets. J Neurol Sci 177:24-31, 2000
13. + memory T lymphocytes in the peripheral blood of multiple sclerosis patients. Clin Diagn Lab Immunol 2:249-252, 1995
14. Mahmoud F, Abul H, al Saleh Q, Hssab el Naby H, Kajeji M, Haines D, Burleson J, Morgan G: Elevated B-lymphocyte levels in lesional tissue of non-arthritic psoriasis. J Dermatol 26:428-433, 1999
15. Granstein RD: New treatments for psoriasis. N Engl J Med 345:284-287, 2001
16. + T cells. Gut 50:299-306, 2002
17. Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol 24(Suppl 170):2-6, 1989
18. Best WR, Becktel JM, Singleton JW, Kern F: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology; 70:439-444, 1976
19. Truelove SC, Witts LJ: Cortisone in ulcerative colitis: Final report on a therapeutic trial. BMJ 2:1041-1048, 1955
20. - natural killer cells subset. Blood 82:1538-1545, 1993
21. Prieto A, Reyes E, Garcia-Suarez J, Carrion F, Hernandez MP, Chafer J, Alvarez-Mon M: A low blood lymphocyte count is associated with an expansion of activated cytotoxic T lymphocytes in patients with B cell chronic lymphocytic leukemia. Eur J Haematol 59:89-99, 1997
22. Prieto A, Reyes E, Diaz D, Hernandez-Fuentes MP, Monserrat J, Perucha E, Muñoz L, Vangioni R, de La Hera A, Orfao A, Alvarez-Mon M: A new method for the simultaneous analysis of growth and death of immunophenotypically defined cells in culture. Cytometry 39:56-66, 2000
23. Prieto A, Diaz D, Barcenilla H, Garcia-Suarez J, Reyes E, Monserrat J, San Antonio E, Melero D, de la Hera A, Orfao A, Alvarez-Mon M: Apoptotic rate: A new indicator for the quantification of the incidence of apoptosis in cell cultures. Cytometry 48:185-193, 2002
24. + T cells. J Exp Med 186:1407-1418, 1997
25. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233-258, 1996
26. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families: Immunol Today 15:321-331, 1994
27. Seder RA, Germain RN, Linsley PS, Paul WE: CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production. J Exp Med 179:299-304, 1994
28. Rulifson IC, Sperling Al, Fields PE, Fitch FW, Bluestone JA: CD28 co-stimulation promotes the production of Th2 cytokines. J Immunol 158:658-665, 1997
29. Warnier G, Duffour MT, Uyttenhove C, Gajewski TF, Lurquin C, Haddada H, Perricaudet M, Boon T: Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. Int J Cancer 67:303-310, 1996
30. + T cells in severe rheumatoid arthritis. Arthritis Rheum 40:1106-1114, 1997
31. - costimulation-independent T cells in multiple sclerosis. J Clin Invest 108:1185-1194, 2001
32. Moosig F, Csemok E, Wang G, Gross WL: Costimulatory molecules in Wegener's granulomatosis (WG): Lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 114:113-118, 1998
33. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM: Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100:2135-2139, 1999.
34. + T cells is associated with the loss of gene-specific nuclear factor binding activity J Biol Chem 273:8119-8129, 1998
35. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97:2027-2037, 1996
36. - T cells. Eur J Immunol 27:1082-1090, 1997
37. - T cells in ankylosing spondylitis. Arthritis Res Ther 5:292-300, 2003
38. (-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol 160:1717-1724, 2002
39. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM: Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 41:2108-2116, 1998
40. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM: De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 93:106-113, 2003
41. Dubey C, Croft M, Swain L: Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J Immunol 157:3280-3289, 1996
42. Hogan LH, Markofski W, Bock A, Barger B, Morrisey JD, Sandor M: Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28. Infect Immun 69:2596-2603, 2001
43. - T cell expansion. Clin Exp Immunol 104:180-184, 1996
44. + T-cell expansions contribute to the unbalanced T-cell receptor repertoire of rheumatoid arthritis patients. Blood 89:2822-2232, 1997
45. + T cells in the disease activity of rheumatoid arthritis. Arthritis Rheum 46: 379-384, 2002
46. - cells, in autoimmune thyroid disease. Clin Exp Immunol 93:430-436, 1993
47. Giscombe R, Nityanand S, Lewin N, Grunewald J, Lefvert AK: Expanded T cell populations in patients with Wegener's granulomatosis: Characteristics and correlates with disease activity. J Clin Immunol 18:404-413, 1998
48. Mackay CR: Migration pathways and immunologic memory among T lymphocytes. Semin Immunol 4:51-58, 1992
49. Autschbach F, Schurmann G, Qiao L, Merz H, Wallich R, Meuer SC: Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Arch 426:51-60, 1995.
50. Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnalek P, Zaradova Z, Palmer T, Donoghue S: Natalizumab for active Crohn's disease. N Engl J Med 348:24-32, 2003
51. Ellis CN, Krueger GG: Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345:248-255, 2001
52. Kraan MC, van Kuijk AW, Dinant HJ, Goedkoop AY, Smeets TJ, de Rie MA, Dijkmans BA, Vaishnaw AK, Bos JD, Tak PP. Alefacept treatment in psoriatic arthritis: Reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. Arthritis Rheum 46:2776-2784, 2002